Legal provisions of COM(2017)735 - Amendment of Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
| dossier | COM(2017)735 - Amendment of Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency. |
|---|---|
| document | COM(2017)735  |
| date | November 14, 2018 |
Article 1
The following Article is inserted in Regulation (EC) No 726/2004:
‘Article 71a
The Agency shall have its seat in Amsterdam, the Netherlands.
The competent authorities of the Netherlands shall take all necessary measures to ensure that the Agency is able to move to its temporary location no later than 1 January 2019 and that it is able to move to its permanent location no later than 16 November 2019.
The competent authorities of the Netherlands shall submit a written report to the European Parliament and the Council on the progress on the adaptations to the temporary premises and on the construction of the permanent building by 17 February 2019, and every three months thereafter, until the Agency has moved to its permanent location.’.
Article 2
This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union.
This Regulation shall apply from 30 March 2019.
This Regulation shall be binding in its entirety and directly applicable in all Member States.